Open an account

PomDoctor

POM · NASDAQ

$1.17−$0.86 (−42.36%)TodayMarket closed ·
Prev close $2.03

About POM

PomDoctor Ltd. operates as an online medical services platform, which specializes in chronic disease management and pharmaceutical services. The company is headquartered in Guangzhou, Guangdong and currently employs 156 full-time employees. The company went IPO on 2025-10-08. The firm's business model focuses on chronic disease management and pharmaceutical services, forming a one-stop medical service platform that connects patients with doctors and pharmaceutical products. The company helps patients to conveniently connect with doctors and obtain one-stop medical services.

Employees
156
Headquarters
Guangzhou, Guangdong
Listed
Oct 8, 2025
Sector
Health Care
Industry
Health Care Providers & Services
Website
7lk.com

POM key statistics

Market cap
7.71M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
29.99M
Volume
4.61M
Open price
$1.56
High today
$1.61
Low today
$1.16
52 Week high
$3.01
52 Week low
$0.69

PomDoctor (POM) at a glance

As of Oct 23, 2026, PomDoctor (POM) shares are priced at $1.17, giving the company a market cap of 7.71M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.16 and $1.61. The current price is 0.9% above the day's low and 27.3% below its high.

Volume so far is 4.61M shares, below the average of 29.99M shares a day.

Over the past year PomDoctor has ranged from $0.69 to $3.01, and now sits 21% of the way up that range.

POM news

  • Avi Kapoor

    Nasdaq Down 400 Points; Tesla Shares Fall After Q3 Results

  • Press releasePRNewswire

    POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq

  • Press releasePRNewswire

    POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare

  • Press releasePRNewswire

    POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination

  • Press releasePRNewswire

    POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization

  • Press releasePRNewswire

    POMDOCTOR LIMITED Highlights Differentiated "Hardware + AI + Payment" Healthcare Infrastructure Model

  • Press releasePRNewswire

    POMDOCTOR LIMITED to Participate in H.C. Wainwright's 28th Annual Global Investment Conference

  • Press releasePRNewswire

    POMDOCTOR LIMITED Initiates U.S. Market Preparation and Unveils Expansion Strategy

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.